2017 DiversityInc Top 50 Announcement Event

Post Tagged with: "Novartis Pharmaceuticals Corporation"

Novartis Foundation welcomes Dr. Vas Narasimhan to Board of Trustees

Novartis Foundation Welcomes Vas Narasimhan to Board of Trustees

"We have much to gain from Dr. Narasimhan’s leadership in both global health and in drug development at Novartis," said Head of the Novartis Foundation Ann Aerts.

Novartis invests in next generation therapies to reduce cardiovascular risk in patients with underlying lipid disorders

Novartis Invests in Next Generation Therapies to Reduce Cardiovascular Risk

Novartis enters into an exclusive option agreement with Ionis and Akcea to license two investigational treatments expected to reduce cardiovascular risk in patients living with elevated levels of lipoprotein.

Novartis Dialogue to Explore Solutions to Rise of Chronic Diseases in Developing World

Novartis Study: SEG101 Antibody Reduces Frequency of Sickle Cell Pain

The results of the sickle cell study are being published in The New England Journal of Medicine.

Novartis Acquires Selexys Pharmaceuticals Corporation, SelG1 Antibody for Pain Reduction in Sickle Cell Disease

Novartis Acquires Selexys Pharmaceuticals Corporation, SelG1 Antibody for Pain Reduction in Sickle Cell Disease

Acquisition complements and broadens Novartis' hematology pipeline and underscores commitment to improving care for patients with high unmet needs.

Novartis' Experimental Treatment Clears Malaria Infections in Small Clinical Study

Experimental Treatment Clears Malaria Infections in Novartis Small Clinical Study

Compound offers a potential tool for fighting drug-resistant malaria parasites.

Novartis Dialogue to Explore Solutions to Rise of Chronic Diseases in Developing World

Novartis Dialogue to Explore Solutions to Rise of Chronic Diseases in Developing World

The event will take place November 29 on the Novartis Campus in Basel, Switzerland and will also be webcast.

Novartis' New Orbis Flying Eye Hospital helps fight blindness in China

Novartis’ New Orbis Flying Eye Hospital Helps Fight Blindness in China

Meet Novartis' flying hospital that brings training to local eye care professionals in under-resourced communities

Novel Novartis Malaria Compound Shows Potential to be Effective Against Infections Resistant to Antimalarial Drugs

Novel Novartis Malaria Compound Shows Potential to be Effective Against Infections Resistant to Antimalarial Drugs

Each year, malaria kills nearly half a million people, most of whom are children.

Point of care in office diagnostics may accelerate treatment decisions that could lead to improved patient care and outcomes

New Novartis Point of Care Niji System May Provide Earlier Diagnosis of Severe Allergic Asthma, Faster Treatment Decisions

Point of care in office diagnostics may accelerate treatment decisions that could lead to improved patient care and outcomes

Novartis: Evolving Business Practices to Better Educate the Medical Community

Novartis: Evolving Business Practices to Better Educate the Medical Community

Novartis is using digital technology to enhance the quality, transparency and reach of its interactions with the medical community.

Accenture Names First Woman As US Group Chief Executive

Accenture named Julie Spellman Sweet to head its U.S. operations. As of next month, four of the six major consulting firms will have women leaders.

Women

Top Companies for Women: What 3 Best Practices They All Have

The companies with the best data for women in management and senior roles use three best practices most frequently – mentoring, employee-resource groups, and flexible workplaces

Novartis Pharmaceuticals Corporation

What Sets The DiversityInc Top 10 Apart?

What is the difference between the Top 10 and the rest of the DiversityInc Top 50? Deep CEO and senior leadership involvement, creating the need for best practices that lead to significant human-capital improvements.

Luke Visconti

NJCU Shows How Diversity and Educational Access Is Done During Gala Event

New Jersey City University honors DiversityInc CEO Luke Visconti and others on a night pressing commitment to diversity and service to the community.

Men Named John Outnumber Women in Key Leadership Positions

Men Named John Outnumber Women in Key Leadership Positions

An economics professor uses an unusual ratio to describe the lack of gender equity at the top level of management.

Geri Jewell at Novartis Pharmaceuticals Corporation

Disability Mentoring Day at Novartis Helped Students Prepare for Workforce

The purpose of the initiative at the company’s East Hanover campus was to share insights with special needs young adults about career possibilities and to help build a diverse local future workforce.

VIDEO: Taking Medicine Personally—Addressing Emerging Patient Needs

Successful medical solutions are personalized, says Novartis Pharmaceuticals Corporation President, Christi Shaw. In a keynote speech, she told DiversityInc’s audience how the drug company is using its knowledge of diverse populations—and its emphasis on an inclusive and innovative workplace—to create the most effective medicines.

VIDEO: How Resource Groups Can Strengthen Employee, Patient and Customer Engagement

Hospitals, health insurers and pharmaceutical companies increasingly rely on employee resource groups to find diverse talent and connect with the communities they serve. Best practices were highlighted by leaders at Novartis Pharmaceuticals Corporation, Mayo Clinic and Blue Cross Blue Shield of Michigan at DiversityInc’s event.

2014 DiversityInc Special Awards Dinner

VIDEO: 2014 DiversityInc Special Awards

CEOs from Accenture, Wyndham, Sodexo, EY, Novartis, MasterCard and Merck share what makes their companies so special as they accept awards at a DiversityInc event in New York City.

Special Awards - Novartis

VIDEO: 2014 Top Company for Diversity Management Progress: Novartis Pharmaceuticals Corporation

NPC President Christi Shaw told DiversityInc’s audience of the sustained leadership commitment and hard work, especially by Chief Diversity Officer Rhonda Crichlow, that helped the company become No. 1 on The DiversityInc Top 50 Companies for Diversity list.

Novartis President Andre Wyss on his company's Journey to No. 1 on the 2014 DiversityInc Top 50

VIDEO: Novartis President André Wyss — ‘Getting to This Point Has Been a Journey’

With 794 people from 302 different companies in attendance, Novartis Pharmaceuticals Corporation was unveiled as the No. 1 company on the 2014 DiversityInc Top 50 list at a special announcement dinner on April 22, 2014, at Cipriani Wall Street in New York City. After ranking in the middle of the pack for a number of …

Ask the White Guy: What Drove Novartis to Become No. 1

Novartis Pharmaceuticals Corporation is a case where successful diversity management grew dramatically because of the support and personal involvement of President André Wyss.

President Barack Obama

Obama Faces Criticism on Multiple Fronts

Is the President’s second-term agenda in jeopardy?

David Epstein, Novartis Pharmaceuticals Corporation, on Diversity and Engagement

Novartis’ David Epstein: A Diverse Team Can ‘Accomplish Feats Nobody Thought Possible’

Having had great success through cultural transformation, this executive is now taking on a bigger challenge as Division Head of Novartis Pharmaceuticals.